Serge Belanger
Stock Analyst at Needham
(4.65)
# 195
Out of 5,148 analysts
396
Total ratings
57.57%
Success rate
25.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 → $58 | $42.55 | +36.31% | 14 | Feb 27, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $34 → $30 | $21.01 | +42.79% | 9 | Feb 27, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $56 → $54 | $41.60 | +29.81% | 28 | Feb 26, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $31 → $36 | $24.76 | +45.40% | 25 | Feb 26, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $25 | $17.68 | +41.40% | 16 | Feb 26, 2026 | |
| LQDA Liquidia | Reiterates: Buy | $52 | $30.94 | +68.07% | 35 | Feb 25, 2026 | |
| CYTK Cytokinetics | Maintains: Buy | $84 → $85 | $61.43 | +38.37% | 27 | Feb 25, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $20 → $18 | $10.98 | +63.93% | 7 | Feb 20, 2026 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $46 → $48 | $32.83 | +46.21% | 11 | Feb 18, 2026 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $42 | $30.25 | +38.84% | 20 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $35 | $16.06 | +117.93% | 24 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $21.28 | +40.98% | 29 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $7.21 | +108.04% | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.29 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $28.61 | +25.83% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.63 | +108.57% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $11.98 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.20 | +150.00% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $12.57 | +75.02% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.37 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $3.27 | +22.32% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.26 | - | 1 | Mar 31, 2022 |
Xenon Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $55 → $58
Current: $42.55
Upside: +36.31%
Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $21.01
Upside: +42.79%
Collegium Pharmaceutical
Feb 26, 2026
Maintains: Buy
Price Target: $56 → $54
Current: $41.60
Upside: +29.81%
Arcutis Biotherapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $31 → $36
Current: $24.76
Upside: +45.40%
MoonLake Immunotherapeutics
Feb 26, 2026
Reiterates: Buy
Price Target: $25
Current: $17.68
Upside: +41.40%
Liquidia
Feb 25, 2026
Reiterates: Buy
Price Target: $52
Current: $30.94
Upside: +68.07%
Cytokinetics
Feb 25, 2026
Maintains: Buy
Price Target: $84 → $85
Current: $61.43
Upside: +38.37%
Ocular Therapeutix
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $10.98
Upside: +63.93%
NewAmsterdam Pharma Company
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $32.83
Upside: +46.21%
Viridian Therapeutics
Feb 4, 2026
Reiterates: Buy
Price Target: $42
Current: $30.25
Upside: +38.84%
Jan 9, 2026
Maintains: Buy
Price Target: $32 → $35
Current: $16.06
Upside: +117.93%
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $21.28
Upside: +40.98%
Jan 8, 2026
Maintains: Buy
Price Target: $16 → $15
Current: $7.21
Upside: +108.04%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.29
Upside: -
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $28.61
Upside: +25.83%
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.63
Upside: +108.57%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.98
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.20
Upside: +150.00%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $12.57
Upside: +75.02%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.37
Upside: -
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.27
Upside: +22.32%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.26
Upside: -